Cerenome (CNSY) Change in Accured Expenses (2010 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | 1.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Mn |
| Mar 31, 2026 | 489,000.00 |
| Dec 31, 2025 | 688,000.00 |
| Sep 30, 2025 | -1.13 Mn |
| Jun 30, 2025 | -2.76 Mn |
| Mar 31, 2025 | -2.42 Mn |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | 966,000.00 |
| Jun 30, 2024 | 403,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Dec 31, 2023 | 384,000.00 |
| Sep 30, 2023 | -472,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | -3.64 Mn |
| Dec 31, 2022 | 4.50 Mn |
| Sep 30, 2022 | 428,000.00 |
| Jun 30, 2022 | 2.18 Mn |
| Mar 31, 2022 | -650,000.00 |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.00 Mn |